1-(6,7-Dimethoxyphthalazin-1-yl)piperidin-4-yl ethylcarbamate, 95.0%, 25mg

(3-Bromo-6-methylpyridin-2-yl)methanol, 97%, 5g

2-Amino-4-thiazolecarboxylic acid hydrobromide, 95.0%, 5g

tert-Butyl-2,2,2-trichloroacetimidate, 97.0%, 25g

Ethyl 2-cyano-4,4-dimethoxybutanoate, 95.0%, 5g

1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 1g

Hexane [Standard Material for GC]>99.5%(GC)5mL

1-Amino-N,N-dimethylcyclopropane-1-carboxamide, 95%, 100mg

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate, 95.0%, 100mg

(4-bromophenyl)(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)acetic acid, 1g

2-Fluoro-5-(trifluoromethyl)benzophenone, 97.0%, 10g

2-Amino-3-bromo-5-chlorobenzotrifluoride, 97.0%, 1g

Sodium tetrachloroplatinate(II) solution 50 g